Healthcare and Pharmaceuticals industry

Gastrointestinal Stromal Tumor Gist Drug Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Gastrointestinal Stromal Tumor Gist Drug Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Gastrointestinal Stromal Tumor Gist Drug Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Gastrointestinal Stromal Tumor Gist Drug Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Ariad Pharmaceuticals, Inc.
  • Arog Pharmaceuticals, Inc.
  • Array BioPharma Inc.
  • Astex Pharmaceuticals, Inc.
  • Blueprint Medicines Corporation
  • Boston Biomedical, Inc.
  • Calithera Biosciences, Inc.
  • Chipscreen Biosciences Ltd
  • Deciphera Pharmaceuticals, LLC
  • F. Hoffmann-La Roche Ltd.
  • Horizon Pharma Plc
  • Immunicum AB
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Kolltan Pharmaceuticals, Inc.
  • Natco Pharma Limited
  • Nerviano Medical Sciences S.r.l.
  • Novartis AG
  • Omeros Corporation

By the Product Type, the market is primarily segmented into:

  • Amcasertib
  • Anagrelide hydrochloride CR
  • APG-1351
  • Binimetinib
  • Others

By Applications, the market is segmented into:

  • Clinic
  • Hospital
  • Others

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Gastrointestinal Stromal Tumor Gist Drug Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Gastrointestinal Stromal Tumor Gist Drug Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Gastrointestinal Stromal Tumor Gist Drug Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Gastrointestinal Stromal Tumor Gist Drug Market

The Gastrointestinal Stromal Tumor Gist Drug Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Gastrointestinal Stromal Tumor Gist Drug Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

Executive Summary
1 Industry Overview of Gastrointestinal Stromal Tumor (GIST) Drug
1.1 Definition of Gastrointestinal Stromal Tumor (GIST) Drug
1.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type
1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Amcasertib
1.2.3 Anagrelide hydrochloride CR
1.2.4 APG-1351
1.2.5 Binimetinib
1.2.6 Others
1.3 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Applications
1.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Overall Market
1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2014-2025)
1.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production (2014-2025)
1.4.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
1.4.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
1.4.5 China Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
1.4.6 Japan Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
1.4.8 India Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
2.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
2.4 Industry Chain Structure of Gastrointestinal Stromal Tumor (GIST) Drug

3 Development and Manufacturing Plants Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
3.1 Capacity and Commercial Production Date
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Gastrointestinal Stromal Tumor (GIST) Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Gastrointestinal Stromal Tumor (GIST) Drug Production and Capacity Analysis
4.2 Gastrointestinal Stromal Tumor (GIST) Drug Revenue Analysis
4.3 Gastrointestinal Stromal Tumor (GIST) Drug Price Analysis
4.4 Market Concentration Degree

5 Gastrointestinal Stromal Tumor (GIST) Drug Regional Market Analysis
5.1 Gastrointestinal Stromal Tumor (GIST) Drug Production by Regions
5.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Regions
5.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Regions
5.2 Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Regions
5.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
5.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Production
5.3.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
5.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
5.4.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production
5.4.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
5.5 China Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
5.5.1 China Gastrointestinal Stromal Tumor (GIST) Drug Production
5.5.2 China Gastrointestinal Stromal Tumor (GIST) Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
5.6 Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
5.6.1 Japan Gastrointestinal Stromal Tumor (GIST) Drug Production
5.6.2 Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
5.7 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
5.7.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production
5.7.2 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
5.8 India Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
5.8.1 India Gastrointestinal Stromal Tumor (GIST) Drug Production
5.8.2 India Gastrointestinal Stromal Tumor (GIST) Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Gastrointestinal Stromal Tumor (GIST) Drug Import and Export

6 Gastrointestinal Stromal Tumor (GIST) Drug Segment Market Analysis (by Type)
6.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Type
6.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type
6.3 Gastrointestinal Stromal Tumor (GIST) Drug Price by Type

7 Gastrointestinal Stromal Tumor (GIST) Drug Segment Market Analysis (by Application)
7.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Application
7.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Application (2014-2019)

8 Gastrointestinal Stromal Tumor (GIST) Drug Major Manufacturers Analysis
8.1 Ariad Pharmaceuticals, Inc.
8.1.1 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.1.2 Ariad Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Arog Pharmaceuticals, Inc.
8.2.1 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.2.2 Arog Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Array BioPharma Inc.
8.3.1 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.3.2 Array BioPharma Inc. Product Introduction, Application and Specification
8.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Astex Pharmaceuticals, Inc.
8.4.1 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.4.2 Astex Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Blueprint Medicines Corporation
8.5.1 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.5.2 Blueprint Medicines Corporation Product Introduction, Application and Specification
8.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Boston Biomedical, Inc.
8.6.1 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.6.2 Boston Biomedical, Inc. Product Introduction, Application and Specification
8.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Calithera Biosciences, Inc.
8.7.1 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.7.2 Calithera Biosciences, Inc. Product Introduction, Application and Specification
8.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Chipscreen Biosciences Ltd
8.8.1 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.8.2 Chipscreen Biosciences Ltd Product Introduction, Application and Specification
8.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Deciphera Pharmaceuticals, LLC
8.9.1 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.9.2 Deciphera Pharmaceuticals, LLC Product Introduction, Application and Specification
8.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 F. Hoffmann-La Roche Ltd.
8.10.1 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.10.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
8.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Horizon Pharma Plc
8.12 Immunicum AB
8.13 Jiangsu Hengrui Medicine Co., Ltd.
8.14 Kolltan Pharmaceuticals, Inc.
8.15 Natco Pharma Limited
8.16 Nerviano Medical Sciences S.r.l.
8.17 Novartis AG
8.18 Omeros Corporation

9 Development Trend of Analysis of Gastrointestinal Stromal Tumor (GIST) Drug Market
9.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Trend Analysis
9.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Gastrointestinal Stromal Tumor (GIST) Drug Regional Market Trend
9.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
9.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
9.2.3 China Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
9.2.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
9.2.5 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
9.2.6 India Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
9.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Trend (Product Type)
9.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Gastrointestinal Stromal Tumor (GIST) Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Table
List of Tables and Figures
Figure Picture of Gastrointestinal Stromal Tumor (GIST) Drug
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Types in 2018
Figure Amcasertib Product Picture
Figure Anagrelide hydrochloride CR Product Picture
Figure APG-1351 Product Picture
Figure Binimetinib Product Picture
Figure Others Product Picture
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) (2014-2025)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) (2014-2025)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Million USD) (2014-2025)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Million USD) (2014-2025)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Million USD) (2014-2025)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Million USD) (2014-2025)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Million USD) (2014-2025)
Table Gastrointestinal Stromal Tumor (GIST) Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in 2018
Figure Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
Figure Industry Chain Structure of Gastrointestinal Stromal Tumor (GIST) Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Plants Distribution
Table Gastrointestinal Stromal Tumor (GIST) Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Gastrointestinal Stromal Tumor (GIST) Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Gastrointestinal Stromal Tumor (GIST) Drug Production Share by Manufacturers in 2018
Table Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers in 2018
Table Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Regions 2014-2019 (K Pcs)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Regions 2014-2019
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Regions in 2018
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions 2014-2019
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions in 2018
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Regions 2014-2019
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption Import and Export (K Pcs)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption Import and Export (K Pcs)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2014-2019)
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Gastrointestinal Stromal Tumor (GIST) Drug by Application (2019-2025)
Table Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
Table Gastrointestinal Stromal Tumor (GIST) Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 



Contact Us

U.S.A :  +1-415-871-0703

JAPAN :  +81-50-5539-1737


Drop Us an email at

[email protected]

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Testimonials

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.